Literature DB >> 15985438

Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment.

Rajeswara Rao Arasada1, Graham Carpenter.   

Abstract

Heregulin activation of the endogenous receptor tyrosine kinase ErbB-4 in ZR-75-1 breast cancer cells provokes tyrosine phosphorylation of Hdm2 in a manner that is sensitive to inhibition of alpha- or gamma-secretase activity, indicating that liberation of the tyrosine kinase intracellular domain (ICD) fragment is required. Similar results are obtained when Erbb-4 is exogenously expressed in 32D cells, which do not otherwise express any ErbB family members. Expression of the ErbB-4 ICD fragment leads to its constitutive association with Mdm2 and tyrosine phosphorylation of Mdm2, a protein that is predominantly localized in the nucleus and that regulates p53 levels. When the ErbB-4 ICD fragment was expressed in H1299 cells, it promoted Hdm2 ubiquitination and increased the levels of p53 and p21, a transcriptional target of p53. In addition, expression of the ICD fragment increased p53 activity toward the p21 promoter in a luciferase reporter assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985438     DOI: 10.1074/jbc.M506057200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Biological function of nuclear receptor tyrosine kinase action.

Authors:  Sungmin Song; Kenneth M Rosen; Gabriel Corfas
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 2.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 3.  HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.

Authors:  Frank E Jones
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-13       Impact factor: 2.673

4.  Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.

Authors:  Rebecca S Muraoka-Cook; Laura S Caskey; Melissa A Sandahl; Debra M Hunter; Carty Husted; Karen E Strunk; Carolyn I Sartor; William A Rearick; Wesley McCall; Magdalene K Sgagias; Kenneth H Cowan; H Shelton Earp
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response.

Authors:  Basak Icli; Ajit Bharti; Laura Pentassuglia; Xuyang Peng; Douglas B Sawyer
Journal:  Biochem Biophys Res Commun       Date:  2012-01-05       Impact factor: 3.575

Review 6.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

Review 7.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

Review 8.  Role of ErbB4 in breast cancer.

Authors:  Maria Sundvall; Kristiina Iljin; Sami Kilpinen; Henri Sara; Olli-Pekka Kallioniemi; Klaus Elenius
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-03       Impact factor: 2.673

Review 9.  ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.

Authors:  David F Stern
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-03       Impact factor: 2.673

10.  Cell death or survival promoted by alternative isoforms of ErbB4.

Authors:  Maria Sundvall; Ville Veikkolainen; Kari Kurppa; Zaidoun Salah; Denis Tvorogov; E Joop van Zoelen; Rami Aqeilan; Klaus Elenius
Journal:  Mol Biol Cell       Date:  2010-10-13       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.